Talphera (TLPH) Gains from Investment Securities (2024 - 2026)
Talphera's (TLPH) quarterly Gains from Investment Securities came in at -$1.2 million in Q1 2026, down 575.69% year-on-year from $257099.9 in Q1 2025, and down 575.69% quarter-over-quarter from -$181000.0 in Q1 2025.
Talphera (TLPH) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Talphera's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Talphera | 92.16 Mn | 92.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2026 | -1.22 Mn |
| Mar 31, 2025 | -181,000.00 |
| Mar 31, 2025 | -181,000.00 |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |